In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Alignment Healthcare Inc (NASDAQ: ALHC) was $17.85 for the day, down -1.27% from the previous closing price of $18.08. In other words, the price has decreased by -$1.27 from its previous closing price. On the day, 3.0 million shares were traded. ALHC stock price reached its highest trading level at $18.3791 during the session, while it also had its lowest trading level at $17.65.
Ratios:
Our analysis of ALHC’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 3.39 whereas as Long-Term Debt/Eq ratio is at 3.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 01 ’25 when JOYCE CHRISTOPHER J sold 25,000 shares for $18.47 per share. The transaction valued at 461,632 led to the insider holds 415,022 shares of the business.
Scavo Robert L. sold 2,864 shares of ALHC for $51,237 on Mar 27 ’25. The Chief Information Officer now owns 702,953 shares after completing the transaction at $17.89 per share. On Mar 27 ’25, another insider, Kardes Hakan, who serves as the Chief Experience Officer of the company, sold 7,225 shares for $17.89 each. As a result, the insider received 129,255 and left with 678,987 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3424201216 and an Enterprise Value of 3285136128. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.27 while its Price-to-Book (P/B) ratio in mrq is 34.28. Its current Enterprise Value per Revenue stands at 1.215 whereas that against EBITDA is -46.002.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.32, which has changed by 2.7978723 over the last 52 weeks, in comparison to a change of 0.101756096 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $18.92, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 15.04%, while the 200-Day Moving Average is calculated to be 51.26%.
Shares Statistics:
ALHC traded an average of 2.25M shares per day over the past three months and 2586490 shares per day over the past ten days. A total of 191.78M shares are outstanding, with a floating share count of 106.32M. Insiders hold about 44.58% of the company’s shares, while institutions hold 56.39% stake in the company. Shares short for ALHC as of 1741910400 were 8266768 with a Short Ratio of 3.68, compared to 1739491200 on 8119817. Therefore, it implies a Short% of Shares Outstanding of 8266768 and a Short% of Float of 6.7299999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
